Axelar AB-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Axelar AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011810
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Axelar AB (Axelar) is a drug development company that develops various novel anti-cancer treatments. The company develops AXL1717, a novel anti cancer compound that inhibits tumor growth and reduces tumor sizes of malignant cells such as prostate cancer, breast cancer, glioblastoma, sarcoma, malignant melanoma and multiple myeloma. It conducts research on inhibitors of insulin-like growth factor-1 receptor and their applications in human diseases. The company develops drugs in therapeutic areas including non-small cell lung cancer such as squamous cell carcinoma and adenocarcinoma. Axelar is headquartered in Solna, Sweden.

Axelar AB – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Axelar AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Axelar AB, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Axelar AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Axelar AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Axelar AB, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Axelar AB, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Axelar Raises US$20 Million In Venture Financing 10
Partnerships 11
Axelar Enters into Co-Development Agreement with Cadila Pharma 11
Acquisition 12
Ostersjostiftelsen Acquires Stake in Axelar from Karolinska Development 12
BrainsToVentures And Rosetta Capital Acquire Minority Stake In 13 Portfolio Companies Of Karolinska Development For US$34 Million 13
Axelar AB – Key Competitors 16
Axelar AB – Key Employees 17
Axelar AB – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Axelar AB, Pharmaceuticals & Healthcare, Key Facts 2
Axelar AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Axelar AB, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Axelar AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Axelar AB, Deals By Therapy Area, 2011 to YTD 2017 8
Axelar AB, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Axelar Raises US$20 Million In Venture Financing 10
Axelar Enters into Co-Development Agreement with Cadila Pharma 11
Ostersjostiftelsen Acquires Stake in Axelar from Karolinska Development 12
BrainsToVentures And Rosetta Capital Acquire Minority Stake In 13 Portfolio Companies Of Karolinska Development For US$34 Million 13
Axelar AB, Key Competitors 16
Axelar AB, Key Employees 17

★海外企業調査レポート[Axelar AB-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Novo Nordisk AS (NOVO B):製薬・医療:M&Aディール及び事業提携情報
    Summary Novo Nordisk A/S (Novo Nordisk), a subsidiary of Novo A/S discovers, develops and manufactures innovative biological medicines. It focuses at developing drugs for treating diabetes and other serious chronic conditions including hemophilia, growth disorders and obesity. The company’s product …
  • IDEXX Laboratories, Inc.:企業の戦略・SWOT・財務情報
    IDEXX Laboratories, Inc. - Strategy, SWOT and Corporate Finance Report Summary IDEXX Laboratories, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Biotest AG (BIO):企業の財務・戦略的SWOT分析
    Biotest AG (BIO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Azure Power India Private Limited (AZRE)-エネルギー分野:企業M&A・提携分析
    Summary Azure Power India Private Limited (Azure) is a renewable energy company that offers solar products. The company designs, installs, produces, finances, owns and operates solar power plants. Its services include engineering, operational performance monitoring, and others. Azure provides off gr …
  • Oakdale Electric Cooperative:発電所・企業SWOT分析
    Oakdale Electric Cooperative – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • National Institutes of Health:企業のM&A・事業提携・投資動向
    National Institutes of Health - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's National Institutes of Health Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • New Zealand Post Ltd:企業の戦略的SWOT分析
    New Zealand Post Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Camping World Holdings, Inc. (CWH):企業の財務・戦略的SWOT分析
    Camping World Holdings, Inc. (CWH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Petroleos Mexicanos-エネルギー分野:企業M&A・提携分析
    Summary Petroleos Mexicanos (PEMEX) is a state owned vertically integrated oil and gas company. The company explores for, develops and produces crude oil and natural gas. It also refines and markets petroleum products. PEMEX gathers and processes natural gas products. It manufactures and markets a w …
  • Protagen Protein Services GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Protagen Protein Services GmbH (PPS), a subsidiary of Zukunftsfonds Heilbronn GmbH & Co KG is a contract research organization that concentrates on protein analytics. The organization offers services including protein characterization, services for biopharmaceuticals, biosimilars services an …
  • Park Group plc:企業の戦略・SWOT・財務情報
    Park Group plc - Strategy, SWOT and Corporate Finance Report Summary Park Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Prologis, Inc.:企業のM&A・事業提携・投資動向
    Prologis, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Prologis, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Coca-Cola Amatil Limited:企業の戦略・SWOT・財務情報
    Coca-Cola Amatil Limited - Strategy, SWOT and Corporate Finance Report Summary Coca-Cola Amatil Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Baytex Energy Corp (BTE):企業の財務・戦略的SWOT分析
    Baytex Energy Corp (BTE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Sino Hotels (Holdings) Limited:企業の戦略・SWOT・財務分析
    Sino Hotels (Holdings) Limited - Strategy, SWOT and Corporate Finance Report Summary Sino Hotels (Holdings) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Symrise AG (SY1):企業の財務・戦略的SWOT分析
    Symrise AG (SY1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • The Jean Coutu Group (PJC) Inc.:戦略・SWOT・企業財務分析
    The Jean Coutu Group (PJC) Inc. - Strategy, SWOT and Corporate Finance Report Summary The Jean Coutu Group (PJC) Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • TAS S.p.A. (TAS):企業の財務・戦略的SWOT分析
    TAS S.p.A. (TAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Gemalto N.V. (GTO):企業の財務・戦略的SWOT分析
    Gemalto N.V. (GTO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Vector Group Ltd.:企業の戦略・SWOT・財務情報
    Vector Group Ltd. - Strategy, SWOT and Corporate Finance Report Summary Vector Group Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆